MedPath

A study to determine the efficacy of avala veera chunnam on gallbladder stone

Phase 2
Not yet recruiting
Conditions
Calculus of gallbladder with acutecholecystitis,
Registration Number
CTRI/2019/07/020396
Lead Sponsor
National Institute of Siddha
Brief Summary

Siddha system of medicine is one of the ancient system of medicine. In siddha system of medicine had 4448 types of disease divided by the great saint’s 18 Siddhars and give a natural types of mecines for above diseases. In this study we have to manage The Cholelithiasis (Gallbladder stone/ Pithapai kal) with siddha fromulation of Pavala Veera Chunnam. In my study patients are selected by selection criterias and found outcome after 2 months with interpretation of USG Abdomen reports. After finishing above study and results of drug on Pithpai kal will be published.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
5
Inclusion Criteria

Asymptomatic cholelithiasis the patients of cholelithiasis as diagnosed by USG Abdomen, Gallbladder stone size less than 10mm.

Exclusion Criteria

Pregnant and lactating mothers, cholecystitis with pancreatitis as diagnosed by USG abdomen, Obstructive Jaundice, Gallstone patients with other comorbidities, patients who did not give consent to join study, malignancy of gallbladder as by reports.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The outcome of the study is assessed by reduction in clinical symptoms and reduction in the size of the stone with interpretation of USG abdomen.2 months with follow once in a week
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

National Institute of Siddha

🇮🇳

Kancheepuram, TAMIL NADU, India

National Institute of Siddha
🇮🇳Kancheepuram, TAMIL NADU, India
Dr B Muthu karthikeyan
Principal investigator
8903441419
b.m.k.keyan@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.